[Asia Economy Reporter Oh Ju-yeon] Jeonjin Bio Pharm announced on the 24th that it has decided to invest 3.7 billion KRW in establishing a new factory (construction of headquarters building and factory). This corresponds to 128.32% of its equity capital.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing